Barcelona 2022

Browse: Pre-Congress Content Sunday, 04.09.2022 Monday, 05.09.2022 Tuesday, 06.09.2022		Monday, 14.11.2022 Tuesday, 15.11.2022 Wednesday, 16.11.2022 Thursday, 17.11.2022 Friday, 18.11.2022

Citations should be made in the following way: Authors. Title. Eur Respir J 2022; 60: Suppl. 66, abstract number.

Interstitial lung diseases in connective tissue diseases: patient’s journey from diagnosis and new treatment strategies to transplantation

Symposium
Chairs: F. Meloni (Pavia (PV), Italy), T. Welte (Hannover, Germany)
Aims: to update attendees about the management of interstitial lung diseases (ILDs) associated with connective tissue diseases (CTD-ILDs), which has recently evolved with the increasing numbers of prescription for antifibrotics in addition to immunosuppressive drugs; to provide an update about diagnostic practice and assess the adjunctive value of a multidisciplinary approach to diagnosis; to describe therapeutic strategies and analyse the timing and contraindications of lung transplant referral as well as post-transplant management and outcomes; to discuss novel insights into the diagnostic procedure and the implication of genetics.

Download all media

Utility of genetic assessment of patients with CTD-ILDs A. Froidure (Bruxelles, Belgium)
CTD-ILDs: diagnosis and new treatment strategies up to transplantation B. Crestani (Paris, France)
What are the main challenges when a CTD-ILD patient is referred for lung transplantation? J. Cifrian Martinez (Santander (Cantabria), Spain)
New trends in treatment of myositis-associated ILD I. Lundberg (Stockholm, Sweden)
Discussion and Q&A